These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2990541)

  • 1. Fluoro ketone inhibitors of hydrolytic enzymes.
    Gelb MH; Svaren JP; Abeles RH
    Biochemistry; 1985 Apr; 24(8):1813-7. PubMed ID: 2990541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition in acetylcholinesterase catalysis: free-energy correlations for substrate turnover and inhibition by trifluoro ketone transition-state analogs.
    Nair HK; Seravalli J; Arbuckle T; Quinn DM
    Biochemistry; 1994 Jul; 33(28):8566-76. PubMed ID: 8031791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues.
    Thaisrivongs S; Pals DT; Kati WM; Turner SR; Thomasco LM; Watt W
    J Med Chem; 1986 Oct; 29(10):2080-7. PubMed ID: 3531517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition kinetics of acetylcholinesterase with fluoromethyl ketones.
    Allen KN; Abeles RH
    Biochemistry; 1989 Oct; 28(21):8466-73. PubMed ID: 2605196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Bromo ketone substrate analogues are powerful reversible inhibitors of carboxypeptidase A.
    Galardy RE; Kortylewicz ZP
    Biochemistry; 1985 Dec; 24(26):7607-12. PubMed ID: 4092028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiotensin converting enzyme by aldehyde and ketone substrate analogues.
    Grobelny D; Galardy RE
    Biochemistry; 1986 Mar; 25(5):1072-8. PubMed ID: 3008817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of carboxypeptidase A by aldehyde and ketone substrate analogues.
    Galardy RE; Kortylewicz ZP
    Biochemistry; 1984 Apr; 23(9):2083-7. PubMed ID: 6547054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of carboxypeptidase A by ketones and alcohols that are isosteric with peptide substrates.
    Grobelny D; Goli UB; Galardy RE
    Biochemistry; 1985 Dec; 24(26):7612-7. PubMed ID: 4092029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of serine proteases by peptidyl fluoromethyl ketones.
    Imperiali B; Abeles RH
    Biochemistry; 1986 Jul; 25(13):3760-7. PubMed ID: 3527255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliphatic ketones are acetylcholinesterase inhibitors but not transition state analogs.
    Dafforn A; Jewell M; Anderson M; Ash D; Horvath D; Kitson R; Margiotta S; Rych G
    Biochim Biophys Acta; 1979 Jul; 569(1):23-30. PubMed ID: 465505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity studies of fluoroketone inhibitors of alpha-lytic protease and human leukocyte elastase.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1990 Jul; 280(1):137-46. PubMed ID: 2353815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoro ketone containing peptides as inhibitors of human renin.
    Fearon K; Spaltenstein A; Hopkins PB; Gelb MH
    J Med Chem; 1987 Sep; 30(9):1617-22. PubMed ID: 3305947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.
    Rich DH; Bernatowicz MS; Agarwal NS; Kawai M; Salituro FG; Schmidt PG
    Biochemistry; 1985 Jun; 24(13):3165-73. PubMed ID: 3927973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pepstatin inhibition mechanism.
    Marciniszyn J; Hartsuck JA; Tang J
    Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidyl fluoro-ketones as proteolytic enzyme inhibitors.
    Sani M; Sinisi R; Viani F
    Curr Top Med Chem; 2006; 6(14):1545-66. PubMed ID: 16918467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorinated aldehydes and ketones acting as quasi-substrate inhibitors of acetylcholinesterase.
    Brodbeck U; Schweikert K; Gentinetta R; Rottenberg M
    Biochim Biophys Acta; 1979 Apr; 567(2):357-69. PubMed ID: 444532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 19F nuclear magnetic resonance spectroscopy study of the complex of 2-benzyl-4-oxo-5,5,5-trifluoropentanoic acid and carboxypeptidase A.
    Teater C; Grobelny D; Galardy RE
    Biochem Biophys Res Commun; 1988 Jun; 153(2):773-8. PubMed ID: 3382403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Phosphonopropionic acids inhibit carboxypeptidase A as multisubstrate analogues or transition-state analogues.
    Grobelny D; Goli UB; Galardy RE
    Biochem J; 1985 Nov; 232(1):15-9. PubMed ID: 4084224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.
    Holladay MW; Salituro FG; Rich DH
    J Med Chem; 1987 Feb; 30(2):374-83. PubMed ID: 3100803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of potent and specific inhibitors of carboxypeptidases A and B.
    Ondetti MA; Condon ME; Reid J; Sabo EF; Cheung HS; Cushman DW
    Biochemistry; 1979 Apr; 18(8):1427-30. PubMed ID: 427123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.